Back to Search
Start Over
Comparative In Vitro Activities of New Antibiotics for the Treatment of Skin Infections
- Source :
- Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
- Publication Year :
- 2019
- Publisher :
- Oxford University Press (OUP), 2019.
-
Abstract
- Bacterial skin infections result in significant morbidity and have contributed to enhanced health-care resource utilization. The problem is heightened by emerging antimicrobial resistance. Multiple novel agents active against resistant pathogens that cause skin infections—including dalbavancin, tedizolid phosphate, oritavancin, and delafloxacin—have been approved over the past 5 years. Common features of these agents include gram-positive activity and favorable safety. Of these agents, delafloxacin is unique in being active against both gram-positive and gram-negative pathogens that cause skin infections, including those resistant to other antimicrobial agents. It is, therefore, an effective option for the treatment of skin infections.
- Subjects :
- 0301 basic medicine
Microbiology (medical)
medicine.drug_class
030106 microbiology
Antibiotics
Supplement Articles
Microbial Sensitivity Tests
Skin infection
Gram-Positive Bacteria
antimicrobial susceptibility
Microbiology
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Antibiotic resistance
delafloxacin
medicine
Humans
030212 general & internal medicine
integumentary system
business.industry
Oritavancin
Dalbavancin
Skin Diseases, Bacterial
medicine.disease
Antimicrobial
Anti-Bacterial Agents
skin infections
Infectious Diseases
chemistry
surveillance
Tedizolid
Delafloxacin
business
Subjects
Details
- ISSN :
- 15376591 and 10584838
- Volume :
- 68
- Database :
- OpenAIRE
- Journal :
- Clinical Infectious Diseases
- Accession number :
- edsair.doi.dedup.....2e78f1fcdcb58eb8b118366c8c8400c7